CTSO
Cytosorbents Corp
NASDAQ · Healthcare · Medical - Devices · US
$4.67
+2.86%Oct 29, 2026, 11:00 UTC
Cytosorbents Corp announced that it will report its third-quarter 2026 financial results and recent business highlights after the market close on November 12, 2026.
Source:Sep 30, 2026, 11:00 UTC
CytoSorbents Corporation announced upcoming data presentations on the use of CytoSorb in open heart surgery at the EACTS Annual Meeting in Barcelona and in critical care at the ESICM Annual Congress in Lisbon in October 2026.
Source:Aug 6, 2026, 20:25 UTC
CytoSorbents Corporation reported its financial results for the second quarter ended June 30, 2026.